Gentherm Reports 2026 Second Quarter Results and Announces a New Increased Stock Repurchase Authorization
Bullish on THRM over 3–6 months driven by buyback and higher guidance; expect multiple expansion as M&A closes.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish on THRM over 3–6 months driven by buyback and higher guidance; expect multiple expansion as M&A closes.
What happened and why it matters
Gentherm delivered a strong Q2 with record quarterly revenue of $416 million and 9.5% ex-FX growth, lifting full-year 2026 guidance. The company also announced a $400 million stock repurchase and progress on the Modine Performance Technologies transaction, expected to close by early Q4 2026. Strategic acquisitions broaden the product portfolio, underscoring a path to higher cash flow and shareholder returns near-term.
Positive quarterly results, raised full-year guidance, and a substantial buyback signal immediate upside potential; M&A progress and new healthcare-related acquisition may broaden growth runway, supporting multiple expansion for THRM. Risks include margin pressure from higher material costs and execution timing of the Modine integration.
Gentherm Q2 2026 revenue $416.2M, up 11% YoY; ex-FX +9.5%.
Guidance for 2026 raised; product revenues $1.55–$1.65B; Adj EBITDA $185–$200M.
Automotive Climate & Comfort Solutions up 14.1% YoY; Automotive revenue up ~9–12% ex-FX.
Board approves new stock repurchase program up to $400M; replaces prior plan.
M&A updates: Modine Performance Technologies deal on track to close by early Q4 2026; Innovative Medical Equipment acquisition expands ThermaZone line.
Earnings with corporate actions and M&A updates; fits earnings category due to guided 2026 outlook and quarterly results, while highlighting strategic moves (buyback and acquisitions) that could affect THRM's valuation and cash flow trajectory.
More AI-analyzed coverage connected to this story